Etiket: kilo kaybı

Weight-Loss Jabs Revolutionizing Shopping: What You Need to Know

Weight-loss medications like Wegovy and Mounjaro are making waves in the UK, with over two million users now relying on these jabs to shed pounds. B

Weight-loss medications like Wegovy and Mounjaro are making waves in the UK, with over two million users now relying on these jabs to shed pounds. But hold on a second! It’s not just about dropping the weight; these meds are also reshaping how folks spend their cash. We’re not talking about a simple dip in spending here – this is a shift in the way people are opening their wallets. You see, it’s not just about “spending less”; it’s about “spending differently.”

A study from Cornell revealed that many people are actually reverting to their old grocery spending habits after adopting these medications. Meanwhile, research has shown that there’s been an 8% drop in spending at fast-food joints and coffee shops. Can you believe that? While these weight-loss jabs might save users some bucks in certain areas, the staggering cost of the drugs is a real worry for many. Most patients in the UK pay out of pocket, and prescriptions can hit over £300 a month. Ouch!

According to a survey conducted by Zava, a service that provides weight-loss medications, the main reason people stop their treatment? You guessed it – the cost! It’s a bitter pill to swallow, especially when you consider that wealthier areas of the UK are seeing more prescriptions, even though those regions have lower obesity rates. It’s a bit of a paradox, isn’t it?

And let’s not forget about Wegovy, the weight-loss pill that’s now available in the UK. This has sparked a lot of conversations about who benefits most from these weight-loss jabs. The landscape of shopping habits is changing, and it’s all tied to these medications. It’s like a domino effect – as people lose weight, they’re also adjusting their spending patterns.

So, what’s next? Are these trends going to stick around, or will we see a shift again? We’re keeping an eye on how this all unfolds and what it means for the future of shopping and health in the UK. Buckle up, because the journey is just beginning!

Kaynak: Orijinal Haber

Weight-Loss Injections Spark a Grocery Spending Revolution!

Weight-loss medications are taking the UK by storm, with more than two million people now using these jabs to shed those stubborn pounds. Medication

Weight-loss medications are taking the UK by storm, with more than two million people now using these jabs to shed those stubborn pounds. Medications like Wegovy and Mounjaro are not just helping folks slim down, they’re turning the shopping habits of users upside down. So, what’s happening on the grocery front? Well, it turns out that these drugs mimic a natural hormone known as GLP-1, which helps regulate appetite. Users have reported that their cravings are under control, leading to some unexpected changes in their shopping carts.

A recent study by Worldpanel by Numerator dug into this trend, analyzing the grocery spending habits of over 11,000 households in February. And guess what? Households with at least one GLP-1 user slashed their grocery spending by an average of £418 in the year following the start of their treatment, compared to those who aren’t using the medication. This adds up to a staggering £780 million drop in grocery expenditures nationwide! Can you believe it? That’s a lot of cash staying in people’s pockets!

This aligns with a peer-reviewed study from Cornell University that reported similar findings in the US. After starting weight-loss medications, households there spent about 5% less on groceries within six months, with the figure climbing to 8% for families with higher incomes. So, what’s driving this shift? Users are cutting back on sweets and snacks, opting instead for healthier options like fruits and protein-rich foods. The report even highlighted a drop in alcohol consumption. Makes sense, right? When you’re feeling fuller for longer, the urge to munch mindlessly tends to fade away.

But hold on, it’s not all about cutting costs. Users have started purchasing more items like chewing gum, mouthwash, and hair dyes, all aimed at combating the common side effects of GLP-1 medications, such as bad breath and hair thinning. Nishita Pattni, a senior consultant at Worldpanel by Numerator, pointed out that these weight-loss jabs are “reshaping” spending rather than just cutting it. It’s not merely about less demand; it’s about different demand altogether.

Interestingly, the research indicated a notable 8% decline in spending at fast-food joints and coffee shops. However, despite these potential savings, the cost of these medications is a significant concern. Most patients in the UK are paying out of their own pockets, with prescriptions sometimes exceeding £300 a month. A survey from Zava, an online pharmacy service, revealed that the primary reason users stopped their medication was the steep price tag. It’s a tough pill to swallow, no pun intended!

Moreover, the Health Foundation noted that wealthier areas of the UK tend to see higher prescription rates, even though they have a lower prevalence of obesity. This raises questions about accessibility and equity in healthcare. As the Wegovy pill becomes more available in the UK, many are left wondering who will truly benefit from these weight-loss jabs.

So, what’s next for these weight-loss medications and their impact on shopping habits? Will grocery stores adapt to this new trend? Only time will tell…

Kaynak: Orijinal Haber

Wegovy Weight Loss Pill Hits UK Pharmacies: What You Should Know!

The once-a-day Wegovy weight loss pill is now available for purchase in pharmacies across the UK, both on High Street and online. This pill, which c

The once-a-day Wegovy weight loss pill is now available for purchase in pharmacies across the UK, both on High Street and online. This pill, which contains the same active ingredient—semaglutide—as the popular Wegovy weight loss injections, is not yet covered by the NHS. So, what’s the scoop on this new medication?

First off, both the pill and the injection have proven effective in clinical trials, leading to similar results for those looking to shed some pounds. If you’re not too keen on daily medication or the jab isn’t your thing, this might be a game-changer for you. However, it’s essential to note that the pill is recommended for individuals with a Body Mass Index (BMI) of 30 and above, which is generally classified as obese. Those with a BMI between 27 and 30, who also have certain weight-related health conditions like diabetes or high blood pressure, may also qualify for this treatment. Essentially, the usage criteria mirror those for the injection.

Now, before you rush to grab a bottle, you’ll need to have a consultation—whether that’s online or in-person—to ensure the pill is suitable for you. Many pharmacies are gearing up to stock these pills, with some even suggesting customers sign up for waiting lists to stay in the loop. The semaglutide in both forms mimics a hormone called GLP-1, which your gut releases after eating. This hormone interacts with brain receptors that manage appetite, helping you feel fuller, less hungry, and with fewer cravings.

But let’s not sugarcoat it—side effects are part of the package! Common complaints include stomach issues like nausea, vomiting, constipation, and diarrhea. Those opting for the injection may also notice some skin redness or mild swelling at the injection site. It’s worth mentioning that while most side effects are manageable, there’s a potential for more serious complications like low blood sugar or pancreatitis. So, it’s wise to stay informed and consult health professionals when making this switch.

As for how to take the pill, it’s pretty straightforward. You should swallow it whole with plain water—no fizzy drinks or coffee here! If you miss a dose, just take it the next day; however, don’t double up. The starting dose is 1.5mg once a day for the first month, and after a consultation, you might gradually increase to a maximum of 25mg daily. Keep in mind that it can take a few months to see the full benefits, and there’s always a risk of gaining weight back after stopping the medication.

Prices for the Wegovy pill vary. Some pharmacies are running introductory offers for the first doses, with the lowest dose currently priced around £99 for a month. Keep an eye out, as prices can fluctuate based on dosage and pharmacy. Earlier this month, Wegovy made headlines by becoming the first weight loss pill of its kind cleared by the Medicines and Healthcare products Regulatory Agency (MHRA). However, experts caution that GLP-1 medications aren’t intended for quick fixes or short-term weight loss solutions. They emphasize the importance of a healthy lifestyle, especially when tempting treats are just a stroll down the street away.

So, what’s the takeaway here? Wegovy has officially landed in UK pharmacies, but it’s essential to approach it with the right mindset and under the guidance of healthcare professionals. Will this new option help those struggling with weight loss? Only time will tell…

Kaynak: Orijinal Haber

Wegovy Weight-Loss Pill Approved in the UK: What You Need to Know

A pill version of the blockbuster weight-loss drug Wegovy has been approved in the UK, meaning folks will soon be able to snag it with a prescription

A pill version of the blockbuster weight-loss drug Wegovy has been approved in the UK, meaning folks will soon be able to snag it with a prescription. This is the first tablet of its kind that has gotten the green light from the Medicines and Healthcare products Regulatory Agency (MHRA). Imagine, no more weekly injections! The manufacturer, Novo Nordisk, claims the once-a-day tablet could be a game changer for many who prefer popping a pill over jabbing themselves with GLP-1 medication that curbs appetite. Plus, these pills don’t even need to be kept in the fridge, which is a nice bonus.

Now, here’s the catch: it won’t be available on the NHS just yet. Experts need to evaluate whether it should be recommended. The National Institute for Health and Care Excellence, the body responsible for making that call, mentioned that Novo Nordisk hasn’t reached out to them yet, but they’re “in active dialogue” with the company. Meanwhile, some high street and online pharmacies are gearing up to add it to their doctor prescribing services in the coming weeks.

According to the MHRA, the starting dose for the tablet is 1.5 mg once daily, which can ramp up to 4 mg, 9 mg, and finally 25 mg, with at least a month spent on each dose level. If you’re currently on the 2.4 mg semaglutide injection weekly, you can switch directly to the 25 mg tablets taken daily. These tablets should be taken on an empty stomach and are already available across the pond in the US. Other companies are either rolling out similar products or working on their own versions.

As for the price? Well, that’s still a bit of a mystery in the UK. But when Wegovy first launched in the US, the starting dose of 1.5 mg was priced at about $149 (around £110) a month. Just like its injection counterpart, the tablets contain semaglutide, which mimics the actions of a natural hormone, GLP-1. This hormone suppresses appetite and slows down digestion, making you feel fuller for longer.

Olivier Picard, the Chair of the National Pharmacy Association, described the approval of the pill as “significant.” He noted that this could really help patients who either can’t or don’t want to take the injectable version. Plus, it might even lower the cost of treatment in the long run. “Pharmacies are waiting for further guidance on when this treatment will be available for patients,” he added.

Trials have shown that these pills are safe and effective. But, just like the injections, it might take a few months to see the full benefits. And there’s always the risk of gaining weight back after stopping the medication. It’s important for anyone taking weight-loss meds to also stick to a healthy diet and get enough exercise. These GLP-1 drugs are not intended for short-term or cosmetic weight loss, and health experts are really pushing back against using them as a quick fix for that “beach body.” Although, let’s be real, some people do misuse them.

Side effects can pop up too, including nausea, diarrhea, constipation, and vomiting. Around a third of UK adults—more than 16 million—struggle with obesity. This new approval could be a big deal for many of them.

Kaynak: Orijinal Haber